Review on Some Plants’ Therapeutic Actions Against Novel Coronavirus (COVID-19) with Gastroenteritis as Contributory Factor
DOI:
https://doi.org/10.31632/ijsblc.2025.v01i02and3.001Keywords:
Medicinal Plant; , Novel-Coronavirus (Covid-19), Severe Acute Respiratory Tract Syndrome (SARS), Therapeutic Action, Transmissible Gastroenteritis Virus (TGEV)Abstract
Coronavirus is an enveloped, multinucleated virus with capability of causing respiratory and enteric ailments in both humans and animals. It resulted to an epidemic SARS with an almost 10% fatality rate. The main aim of the review, is to access some important metabolites or compounds from plants that have therapeutic actions against the novel Coronavirus. Search engines have been utilized in looking for updated findings in regards to this review, so as to provide a sound and reliable information. Moreover, other important CoV including: transmissible gastroenteritis virus of swine (TGEV), porcine epidemic diarrhoea (PEDV) virus and crystal structure of transmissible gastroenteritis virus (TGEV) which resulted to many severe cases and similar to SAR-CoV which antagonised the host innate immune responses. Coronavirus (Covid-19), occurred in the late 2019 at Wuhan, China and later to other countries within a shorter period. The novel virus, triggered in the search of new compounds from various plants species, so as to develop a valuable drug that can get rid of its problems. Many compounds from medicinal plants have clearly shown to be therapeutically active against the viral replications. Some formulations granted to COVID-19 confirmed patients were good in curtailing the tragic Coronavirus infections in China, which were also recommended for future used. So many environmental factors have contributed towards its emergence, where by serious actions need to be taken to get rid of.
References
Abdallah, M. S. ‘Review on Emerging and Reemerging Infectious Diseases and TheirOrigins’, Microbiology Research Journal International, (2019). 26(1), pp. 1–5. https://doi.org/10.9734/mrji/2018/39953
Abdallah, M. S., Mustafa, M., Nallappan, M. & R. Go. ‘Review on Some Plants ’ Therapeutic Effects against Gastrointestinal Microbes’, Annual reviews and research in biology, (2019),31(6), pp. 1–8. https://doi.org/10.9734/ARRB/2019/v31i630066
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature microbiology, 5(4), 536–544. https://doi.org/10.1038/s41564-020-0695-z
Bellini, W. J., & Us, G. A. ( 12 ) United States Patent, (2007). 1(12).
Drexler, J. F., Gloza-Rausch, F., Glende, J., Corman, V. M., Muth, D., Goettsche, M., ... & Drosten, C. (2010). Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences. Journal of virology, 84(21), 11336-11349. https://doi.org/10.1128/jvi.00650-10
Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of medical virology, 92(4), 418-423. https://doi.org/10.1002/jmv.25681
Keyaerts, E., Li, S., Vijgen, L., Rysman, E., Verbeeck, J., Van Ranst, M., & Maes, P. (2009). Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrobial Agents and Chemotherapy, 53(8), 3416-3421. https://doi.org/10.1128/AAC.01509-08
Feied, C. (2004). Novel antimicrobial surface coatings and the potential for reduced fomite transmission of SARS and other pathogens, 1–22. Available at: https://graphics8.nytimes.com/images/blogs/freakonomics/pdf/FeiedAntimicrobialSurfaces.pdf
Wińska, K., Mączka, W., Łyczko, J., Grabarczyk, M., Czubaszek, A., & Szumny, A. (2019). Essential oils as antimicrobial agents—myth or real alternative? Molecules, 24(11). https://doi.org/10.3390/molecules24112130
Rao, K., Verma, P., Kumar, K., Verma, M. K., Siddiqui, A. H., Singh, S., ... & Aryal, S. (2020). Review on Newly Identified Coronavirus and its Genomic Organization. https://doi.org/10.21276/SSR-IIJLS.2020.6.2.5
Lau, K. M., Lee, K. M., Koon, C. M., Cheung, C. S. F., Lau, C. P., Ho, H. M., ... & Fung, K. P. (2008). Immunomodulatory and anti-SARS activities of Houttuynia cordata. Journal of ethnopharmacology, 118(1), 79-85. https://doi.org/10.1016/j.jep.2008.03.018
Lim, K. S., & Kam, P. C. A. (2008). Chlorhexidine-pharmacology and clinical applications. Anaesthesia and intensive care, 36(4), 502-512. https://doi.org/10.1177/0310057x0803600404
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020). Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance, 25(10). https://doi.org/10.2807/1560-7917.es.2020.25.10.2000180
Muluye, R. A., Bian, Y., & Alemu, P. N. (2014). Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review. Journal of traditional and complementary medicine, 4(2), 93-98. https://doi.org/10.4103/2225-4110.126635
Sawadogo, W. R., Schumacher, M., Teiten, M. H., Dicato, M., & Diederich, M. (2012). Traditional West African pharmacopeia, plants and derived compounds for cancer therapy. Biochemical pharmacology, 84(10), 1225-1240. https://doi.org/10.1016/j.bcp.2012.07.021
Redeploying plant defences (2020). Nature Plants, 6. https://doi.org/10.1038/s41477-020-0628-0
Shanmugaraj, B., Malla, A., & Phoolcharoen, W. (2020). Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development. Pathogens, 9(2). https://doi.org/10.3390/pathogens9020148
Li, S. Y., Chen, C., Zhang, H. Q., Guo, H. Y., Wang, H., Wang, L., ... & Tan, X. (2005). Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral research, 67(1), 18-23. https://doi.org/10.1016/j.antiviral.2005.02.007
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., ... & Baric, R. S. (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature communications, 11(1). https://doi.org/10.1038/s41467-019-13940-6
Cheng, V. C., Lau, S. K., Woo, P. C., & Yuen, K. Y. (2007). Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical microbiology reviews, 20(4), 660-694. https://doi.org/10.1128/cmr.00023-07
Wong, S. S., & Yuen, K. Y. (2008). The management of coronavirus infections with particular reference to SARS. Journal of antimicrobial chemotherapy, 62(3), 437-441. https://doi.org/10.1093/jac/dkn243
He, W., Han, H., Wang, W., & Gao, B. (2011). Anti-influenza virus effect of aqueous extracts from dandelion. Virology journal, 8, 1-11. https://doi.org/10.1186/1743-422X-8-538
Hu, X., Tian, J., Kang, H., Guo, D., Liu, J., Liu, D., ... & Qu, L. (2017). Transmissible gastroenteritis virus papain‐like protease 1 antagonizes production of interferon‐β through its deubiquitinase activity. BioMed Research International, 2017(1). https://doi.org/10.1155/2017/7089091
Yang, J. L., Ha, T. K. Q., & Oh, W. K. (2016). Discovery of inhibitory materials against PEDV corona virus from medicinal plants. Japanese Journal of Veterinary Research, 64, S53-S63. https://doi.org/10.14943/jjvr.64.suppl.s53
Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. International Journal of Biological Sciences, 16(10), 1708–1717. https://doi.org/10.7150/ijbs.45538
Zhang, D. H., Wu, K. L., Zhang, X., Deng, S. Q., & Peng, B. (2020). In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of integrative medicine, 18(2), 152-158. https://doi.org/10.1016/j.joim.2020.02.005
Zhang, L., & Liu, Y. (2020). Potential interventions for novel coronavirus in China: A systematic review. Journal of medical virology, 92(5), 479-490. https://doi.org/10.1002/jmv.25707
Zhou, Y., Wu, W., Xie, L., Wang, D., Ke, Q., Hou, Z., ... & Fang, L. (2017). Cellular RNA helicase DDX1 is involved in transmissible gastroenteritis virus nsp14-induced interferon-beta production. Frontiers in Immunology, 8. https://doi.org/10.3389/fimmu.2017.00940
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Sustainable Biome and Life Care
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
